dehydroepiandrosterone has been researched along with piroxicam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kelloff, G; Rao, CV; Reddy, BS; Rigotty, J; Tokumo, K; Zang, E | 1 |
| Boone, CW; Fay, JR; Kelloff, GJ; Malone, WF; Sigman, CC | 1 |
1 review(s) available for dehydroepiandrosterone and piroxicam
| Article | Year |
|---|---|
Progress in applied chemoprevention research.
Topics: Animals; Antineoplastic Agents; Dehydroepiandrosterone; Drug Evaluation; Eflornithine; Fenretinide; Humans; Molybdenum; Neoplasms; Piroxicam; Tretinoin | 1990 |
2 other study(ies) available for dehydroepiandrosterone and piroxicam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Topics: Animals; Body Weight; Colonic Neoplasms; Dehydroepiandrosterone; Drug Combinations; Drug Evaluation, Preclinical; Eflornithine; Ellagic Acid; Intestinal Neoplasms; Intestine, Small; Male; Neoplasms, Multiple Primary; Piroxicam; Rats; Rats, Inbred F344 | 1991 |